Foghorn Therapeutics Inc (FHTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $5.76
• Market Cap: $339.77M
• EPS: $-1.14
• 52-Week High: $6.95
• 52-Week Low: $2.94

Market Sentiment

Foghorn Therapeutics Inc currently has a Bullish sentiment score of 0.33.

About Foghorn Therapeutics Inc

Foghorn Therapeutics Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, focused on pioneering therapies that target genetic dependencies within the chromatin regulatory system. Utilizing its proprietary Gene Traffic Control platform, the company is advancing a promising pipeline of therapeutic candidates aimed at treating various cancers and genetic disorders, thereby establishing itself as a key player in the precision medicine landscape. With a com...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Foghorn Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FHTX pay dividends?

Foghorn Therapeutics Inc (FHTX) does not currently pay a regular dividend.

What is FHTX's market cap?

Foghorn Therapeutics Inc (FHTX) has a market capitalization of $339.77M with a current stock price of $5.76.